Targeting AML with Multi-Antigen Specific T Cells Engineered to Express a CAR Specific for SSX2 Peptide 41-49

被引：0
|
作者：
Pezzella, Gloria [1 ]
Achour, Achouak [1 ]
Yvon, Eric S. [2 ]
Bollard, Catherine M. [1 ,2 ]
Toner, Keri [1 ,2 ]
机构：
[1] Childrens Natl Hosp, Washington, DC USA
[2] George Washington Univ, Washington, DC USA
来源：
MOLECULAR THERAPY | 2024年 / 32卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
142
引用
收藏
页码：77 / 78
页数：2
相关论文
共 50 条
  • [41] Potent activity of CAR T cells targeting the oncofetal protein GPC2 engineered to recognize low antigen density in neuroblastoma.
    Heitzeneder, Sabine
    Bosse, Kristopher R.
    Zhu, Zhongyu
    Jelev, Dontcho
    Dhingra, Shaurya
    Majzner, Robbie
    Sotillo-Pineiro, Elena
    Buongervino, Samantha
    Xu, Peng
    Huang, Jing
    Delaidelli, Alberto
    Hasselblatt, Martin
    Parker, Kevin
    Anbunathan, Hima
    Alag, Anya
    Hwang, Jennifer
    Huang, Min
    Klysz, Dorota D.
    Theruvath, Johanna L.
    Vilches-Moure, Jose G.
    Satpathy, Ansuman T.
    Sorensen, Poul H.
    Dimitrov, Dimiter S.
    Maris, John M.
    Mackall, Crystal L.
    CANCER RESEARCH, 2021, 81 (13)
  • [42] TARGETING OF ACUTE MYELOID LEUKEMIA (AML) BY CYTOKINE-INDUCED KILLER (CIK) CELLS REDIRECTED WITH A NOVEL CD123-SPECIFIC CHIMERIC ANTIGEN RECEPTOR (CAR)
    Tettamanti, S.
    Marin, V.
    Pizzitola, I.
    Magnani, C. F.
    Attianese, G. M. Giordano
    Cribioli, E.
    Maltese, F.
    Lopez, A.
    Biondi, A.
    Bonnet, D.
    Biagi, E.
    CYTOTHERAPY, 2013, 15 (04) : S37 - S37
  • [43] Targeting of acute myeloid leukaemia (AML) by cytokine-induced killer (CIK) cells redirected with a novel CD123-specific chimeric antigen receptor (CAR)
    Tettamanti, S.
    Marin, V.
    Pizzitola, I.
    Magnani, C.
    Attianese, G. Giordano
    Cribioli, E.
    Maltese, F.
    Lopez, A.
    Biondi, A.
    Bonnet, D.
    BONE MARROW TRANSPLANTATION, 2013, 48 : S73 - S73
  • [44] Chimeric antigen receptor (CAR+) modified T cells targeting prostate specific membrane antigen (PSMA) in patients (pts) with castrate metastatic prostate cancer (CMPC)
    Slovin, Susan F.
    Wang, Xiuyan
    Hullings, Melanie
    Arauz, Gabrielle
    Bartido, Shirley
    Lewis, Jason Stuart
    Schoeder, Heiko
    Zanzonico, Pat
    Scher, Howard I.
    Riviere, Isabelle
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [45] Proinsulin multi-peptide immunotherapy induces antigen-specific regulatory T cells and limits autoimmunity in a humanized model
    Gibson, V. B.
    Nikolic, T.
    Pearce, V. Q.
    Demengeot, J.
    Roep, B. O.
    Peakman, M.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2015, 182 (03): : 251 - 260
  • [46] Generation of alloantigen-specific T regulatory cells via a chimeric antigen receptor targeting HLA-A2
    MacDonald, Katherine Grace
    Hoeppli, Romy
    Huang, Qing
    Gillies, Jana
    Luciani, Dan
    Orban, Paul
    Broady, Raewyn
    Levings, Megan K.
    JOURNAL OF IMMUNOLOGY, 2016, 196
  • [47] Directed targeting of B-cell maturation antigen-specific CAR T cells by bioinformatic approaches: From in-silico to in-vitro
    Moazzeni, Ali
    Kheirandish, Maryam
    Khamisipour, Gholamreza
    Rahbarizadeh, Fatemeh
    IMMUNOBIOLOGY, 2023, 228 (03)
  • [48] A foundation for universal T-cell based immunotherapy: T cells engineered to express a CD19-specific chimeric-antigen-receptor and eliminate expression of endogenous TCR
    Torikai, Hiroki
    Reik, Andreas
    Liu, Pei-Qi
    Zhou, Yuanyue
    Zhang, Ling
    Maiti, Sourindra
    Huls, Helen
    Miller, Jeffrey C.
    Kebriaei, Partow
    Rabinovitch, Brian
    Lee, Dean A.
    Champlin, Richard E.
    Bonini, Chiara
    Naldini, Luigi
    Rebar, Edward J.
    Gregory, Philip D.
    Holmes, Michael C.
    Cooper, Laurence J. N.
    BLOOD, 2012, 119 (24) : 5697 - 5705
  • [49] Chimeric antigen receptor (CAR+) modified T cells targeting prostate-specific membrane antigen (PSMA) in patients (pts) with castrate metastatic prostate cancer (CMPC)
    Slovin, Susan F.
    Wang, Xiuyan
    Hullings, Melanie
    Arauz, Gabrielle
    Bartido, Shirley
    Lewis, Jason Stuart
    Schoeder, Heiko
    Zanzonico, Pat
    Scher, Howard I.
    Sadelain, Michel
    Riviere, Isabelle
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (06)
  • [50] CD19 CHIMERIC ANTIGEN RECEPTOR (CAR) ENGINEERED EPSTEIN-BARR VIRUS (EBV) SPECIFIC T CELLS - AN OFF-THE-SHELF, ALLOGENEIC CAR T-CELL IMMUNOTHERAPY PLATFORM
    Shen, R. R.
    Pham, C. D.
    Wu, M.
    Munson, D. J.
    Aftab, B. T.
    CYTOTHERAPY, 2019, 21 (05) : S11 - S11
12345